Anthos Therapeutics has announced that Abelacimab has received FDA Fast Track Designation for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
BRYN MAWR, Pa. (PRWEB) November 24, 2021 Author Peter Kowey, MD returns to the publishing scene as he finally reveals the fifth installment in his “Sarkis